Company Overview - Intelligent Bio Solutions Inc. (INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [6] - The company aims to revolutionize portable testing through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat for drug use [6] Partnership and Product Expansion - INBS announced a global distribution agreement with SMARTOX® to introduce the SmarTest Patch drug detection product to international markets outside the U.S. and Canada [1][2] - The SmarTest Patch enhances INBS's product portfolio by providing continuous sweat-based drug detection over an extended period, targeting sectors such as justice and rehabilitation [2][3] Market Potential - The global drug testing market is projected to grow significantly, reaching approximately $18.6 billion by 2030, presenting new opportunities for INBS [2] - The partnership with SMARTOX supports INBS's international growth strategy and introduces an additional revenue stream aligned with its broader expansion goals [2] Regulatory Strategy - INBS is prioritizing securing FDA clearance for its fingerprint sweat-based drug testing technology for use beyond forensic settings as part of its U.S. expansion strategy [4] - The company is actively engaging with regulatory consultants and stakeholders to bring its innovative solution to market in the U.S. [4] Current Operations - INBS currently serves over 450 active accounts in 24 countries, providing non-invasive drug testing solutions across health, justice, and workplace sectors [3]